Table 3. Multivariate analyses for DFS,... | American Society of Hematology

Table 3.

Multivariate analyses for DFS, duration of CR, and overall survival

	P
	DFS	CR duration	Overall survival
Age, continuous variable	.16	.35	.10
WBC index, 3-group classification	.003	.002	.04
Hazard ratio (95% CI)	1.9 (1.3-3.0)	2.2 (1.3-3.7)	1.6 (1.0-2.6)
AA-AN, 2-group classification	.50	.75	.38
Six prospective studies^3-150	.48	.99	.55
Postremission therapy, ALLO/CHEMO classification	.89	.15	.60

	P
	DFS	CR duration	Overall survival
Age, continuous variable	.16	.35	.10
WBC index, 3-group classification	.003	.002	.04
Hazard ratio (95% CI)	1.9 (1.3-3.0)	2.2 (1.3-3.7)	1.6 (1.0-2.6)
AA-AN, 2-group classification	.50	.75	.38
Six prospective studies^3-150	.48	.99	.55
Postremission therapy, ALLO/CHEMO classification	.89	.15	.60

LAME-91, ALFA-9000, BGMT-87, BGMT-91, GOELAM-01, or GOELAM-02.